Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03744949
Other study ID # 2018-1410
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 14, 2018
Est. completion date September 30, 2021

Study information

Verified date October 2021
Source Ciusss de L'Est de l'Île de Montréal
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Our aim, in this study, is to elucidate the optimal dosing range (ED50 and ED95) of bolus remifentanil in order to counter the painful stimuli resulting from direct laryngoscopy and tracheal intubation by using the NOL index. In order to maximize the clinical relevance of our findings, induction of general anesthesia will be done with standard medications and doses and laryngoscopy will be done with the Macintosh laryngoscope, the most common tool used for intubation in the operating room


Description:

Background: There are no study so far that determined the ED50 and ED95 of remifentanil to perform tracheal intubation by using the NOL index as the criterion measured to determine the failure (painful intubation) or the success (pain free intubation) of the assessed procedure. Objectives: To determine the ED50 and ED95 of remifentanil bolus to perform tracheal intubation without NOL index variating over threshold for nociceptive response (determined as a NOL index going over 20 - peak value of maximum 20) using the Macintosh blade when obtaining good conditions of intubation in anesthetized patients. Good conditions of intubation will be determined as obtaining a Cormack-Lehane grade I and II.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date September 30, 2021
Est. primary completion date October 19, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - ASA status I or II - Mallampati class I or II - Patients > 18 years old and <65 years (defining elderly patients) - Elective general, gynecological, orthopedic, plastic or urological surgery under general anesthesia - Type of surgery that usually necessitate endotracheal intubation and controlled ventilation Exclusion Criteria: - Patient refusal - History of psychiatric diseases or psychological problems (including mental retardation); inability to give consent; language barrier. - Anticipated difficult airway (Mallampati class III and IV, thyromental distance < 6 cm, mouth opening < 3 cm, neck extension <80° and neck flexion <35°, inability to prognath, meaning bringing lower mandibular before the upper maxilla) - Patient with history of neck rigidity or instability - BMI > 30 kg/m2 - Anticipated difficult ventilation (patients with beard, obesity with BMI more than 30 kg/m2) - Patient with history of oropharyngeal or tracheal surgery (excluding adenoidectomy, tonsillectomy and teeth removal) - Severe coronary artery disease - Serious cardiac arrhythmias (including atrial fibrillation) - Use of ß-blockers (all types) - History of opioid or illicit drug substance abuse - Chronic use of psychotropic and/or opioid drugs - Allergy to remifentanil or propofol - Pregnancy - Contraindications to mask ventilation (gastrointestinal tract obstruction, pregnancy, active not-treated gastroesophageal reflux disease, non-fasting patients) - Unexpected difficult airway requesting excessive, possibly painful airway manipulations - Requiring hemodynamic support with vasopressors or inotropes 2 min before laryngoscopy to 5 min after insertion of endotracheal tube

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Remifentanil dose 0.5 ug/kg
Remifentanil will be given (dosage of 0.5 µg/kg of adjusted body weight bolus) from an infusion pump over 30 seconds
Remifentanil dose 1 ug/kg
Remifentanil will be given (dosage of 1 µg/kg of adjusted body weight bolus) from an infusion pump over 30 seconds
Remifentanil dose 1.5 ug/kg
Remifentanil will be given (dosage of 1.5 µg/kg of adjusted body weight bolus) from an infusion pump over 30 seconds
Remifentanil dose 2 ug/kg
Remifentanil will be given (dosage of 2 µg/kg of adjusted body weight bolus) from an infusion pump over 30 seconds

Locations

Country Name City State
Canada Hopital Maisonneuve Rosemont Montréal-Est Quebec

Sponsors (1)

Lead Sponsor Collaborator
Ciusss de L'Est de l'Île de Montréal

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary determine ED95 of remifentanil bolus in mcg/kg for tracheal intubation The primary goal of this study is to determine the ED95 of remifentanil bolus to perform tracheal intubation without NOL index varying over 20 (peak maximal value of 20) using the Macintosh blade when obtaining a Cormack-Lehane grade I or II of intubation in anesthetized patients (the size of the blade will be chosen according to patient characteristics described in the user's manual for each blade and published in previous literature). This primary outcome will be expressed in mcg/kg of remifentanil. in the surgery
Secondary NOL maximal value after intubation (NOL is an index without unit going from 0 to 100) After tracheal intubation NOL index maximal value will be evaluated and compared between the 4 doses of remifentanil in mcg/kg received in this study. in the surgery
Secondary Variation of NOL index after tracheal intubation; DELTA NOL (no unit) After tracheal intubation DELTA NOL index will be evaluated and compared between the 4 doses of remifentanil in mcg/kg received in this study. in the surgery
Secondary Time in seconds NOL spends above 25 after tracheal intubation (in seconds) Time in seconds spent above 25 of NOL index and comparison between the 4 doses of remifentanil used in this study in the surgery
Secondary Area under the curve for NOL index after tracheal intubation (no unit) Compare the AUC of NOL after tracheal intubation between the 4 doses of remifentanil used in this study. in the surgery
Secondary Heart Rate Maximal value after tracheal intubation (in beat per minutes) To compare maximal heart rate values reached after tracheal intubation between the 4 doses of remifentanil used in this study in the surgery
Secondary Heart Rate variation (DELTA Heart Rate) after tracheal intubation (in beats per minute) To compare the DELTA Heart Rate after tracheal intubation between the 4 doses of remifentanil used in this study in the surgery
Secondary Time in seconds that Heart Rate spends above threshold of 10%; in seconds To compare the time in seconds between the 4 doses of remifentanil that Heart Rate spends above teh threshold of 10% of variation above normal prestimulus values. in the surgery
Secondary Area under the curve of Heart Rate after tracheal intubation (no unit) To compare AUC of Heart Rate values after tracheal intubation between teh 4 different doses of remifentanil used in this study. in the surgery
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05535127 - Sequential Strategy vs Palpation vs Routine Ultrasound for Detection of Cricothyroid Membrane N/A
Not yet recruiting NCT05036460 - Real-time Sonography in Detecting Inadvertent Esophageal Intubation Among Difficult Intubation Patients N/A
Completed NCT05303948 - Evaluation of Two Positions for Free Floating Tracheal Intubation in Weightlessness N/A
Completed NCT06107751 - Ramped and Sniffing Position for Cesarean Section Intubation. N/A
Completed NCT04089540 - New Intubation Method to Achieve Circulatory Stability and to Reduce Number of Intubation Attempts in Neonates N/A
Completed NCT05522049 - Videolaryngoscopic Intubation Using Macintosh vs.Hyperangulated Blades in Patients With Expected Difficult Intubation N/A
Completed NCT03046966 - Manikin To Patient Intubation: Does It Translate? N/A
Not yet recruiting NCT05130645 - Evaluation of Mandibular Mental Angle and Mandibular Profile Angle
Completed NCT06042829 - Impact of Covid-19 Aerosol Box On Intubation Success Rate N/A
Completed NCT06138119 - The Impact of Gender Stereotypes on Fiberoptic Intubation Performance N/A
Not yet recruiting NCT06115694 - Comparison of Video Laryngoscopy With Rigid Stylet vs Video Laryngoscopy With the TCI Articulating Introducer for Endotracheal Intubation in Simulated Difficult Airways N/A
Completed NCT05243758 - Who is Rapid And Success? The Comparison Of Video Fiberscope And Video Laryngoscope N/A
Completed NCT04833166 - Comparing Full vs. Partial Glottis View Using CMAC D-Blade Video Laryngoscope in Simulated Cervical Injury Patient N/A
Completed NCT03118596 - Fibre-optic Guided Tracheal Intubation Through SADs N/A
Recruiting NCT05680909 - Evaluation of SaCo Videolaryngeal Mask Airway in Morbidly Obese
Recruiting NCT05429112 - Flexible Tip Bougie vs Tube With Stylet for Intubation With a Videolaryngoscopy in ICU (VIDEOL-FLEXTIP) N/A
Completed NCT05833347 - Evaluation of Difficult Laryngoscopy With Ultrasonography in Pediatric Patients
Completed NCT05366582 - Neural Integrity Monitor Electromyogram (NIM-EMG) Endotracheal Tube Intubation With Video Laryngoscope N/A
Recruiting NCT06322719 - Hyperangulated vs Macintosh Blades for Intubation With Videolaryngoscopy in ICU N/A
Recruiting NCT06213389 - Comparison of EzVision® Videolaryngoscope and Gum Elastic Bougie-Assisted Machintosh Laryngoscopy N/A